Droloxifene, a new antiestrogen, in advanced breast cancer. A double-blind dose-finding study. The Droloxifene 002 International Study Group (Q37559248)
scientific article published on January 1991
Language:
Current Data About Droloxifene, a new antiestrogen, in advanced breast cancer. A double-blind dose-finding study. The Droloxifene 002 International Study Group
(P31) (Q13442814)
(P248)
(P698) 1962599
(P813) Monday, August 21, 2017

(P304) S52-5
(P248)
(P698) 1962599
(P813) Monday, August 21, 2017

(P407) (Q1860)
(P887)

(P478) 14 Suppl 2
(P248)
(P698) 1962599
(P813) Monday, August 21, 2017

(P577) Tuesday, January 1, 1991
(P248)
(P698) 1962599
(P813) Monday, August 21, 2017

(P1433) (Q2886177)
(P248)
(P698) 1962599
(P813) Monday, August 21, 2017

(P1476) "Droloxifene, a new antiestrogen, in advanced breast cancer. A double-blind dose-finding study. The Droloxifene 002 International Study Group" (language: en)
(P248)
(P698) 1962599
(P813) Monday, August 21, 2017

(P2093) Deschênes L
(P1545) 1
(P248)
(P698) 1962599
(P813) Monday, August 21, 2017

other details
description scientific article published on January 1991

External Links
(P698) 1962599